Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease. - Wikidata - awgldk - TriplyDB

Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease.

Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease.

http://www.wikidata.org/entity/Q33695621

about

The role of severe acute respiratory syndrome (SARS)-coronavirus accessory proteins in virus pathogenesis Animal models for SARS and MERS coronaviruses Coronavirus virulence genes with main focus on SARS-CoV envelope gene Coronavirus reverse genetic systems: infectious clones and replicons Current advancements and potential strategies in the development of MERS-CoV vaccines A decade after SARS: strategies for controlling emerging coronaviruses Structure of a conserved Golgi complex-targeting signal in coronavirus envelope proteins Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis.Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis.Coronaviruses: an overview of their replication and pathogenesis.Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge Protein-Protein Interactions of Viroporins in Coronaviruses and Paramyxoviruses: New Targets for Antivirals?A Coronavirus E Protein Is Present in Two Distinct Pools with Different Effects on Assembly and the Secretory Pathway.Coronavirus envelope (E) protein remains at the site of assembly Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids.Identification of the Mechanisms Causing Reversion to Virulence in an Attenuated SARS-CoV for the Design of a Genetically Stable Vaccine.Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein.Virus Infection and Titration of SARS-CoV in Mouse Lung.Measurement of CD8 and CD4 T Cell Responses in Mouse Lungs.Middle East respiratory syndrome vaccines.Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.Animal models in virus research: their utility and limitations.Self-Replicating RNA.Channel-Inactivating Mutations and Their Revertant Mutants in the Envelope Protein of Infectious Bronchitis Virus.Molecular epidemiology and phylogenetic analysis of porcine epidemic diarrhea virus (PEDV) field isolates in Korea.Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis.Viral metagenomics, protein structure, and reverse genetics: Key strategies for investigating coronaviruses.Combination Attenuation Offers Strategy for Live Attenuated Coronavirus Vaccines

P2860

Q24605877-4DB206B5-6573-488A-A3BA-C1C42B67E965 Q26799857-7F8276B9-B570-46DA-B91D-BCF34ACE1791 Q26827561-D176C5A5-9CEC-4805-B230-5BC7BE647EE2 Q26863163-3356E2BB-2D8A-43E0-939E-222FB28DA554 Q27012578-876F0625-CC5B-49E7-9011-A5C08CF87325 Q28817689-6754FCEB-F17B-44C4-A999-8FA21DB34E3A Q30360640-49A9297E-FA7F-4D44-8614-B76F558575AC Q33553636-AF19AE9D-6CD5-47E9-A371-D8CA67B58FD1 Q34047499-6546F172-8A5F-481D-994D-5A518E26A274 Q34058136-A2D2C960-CD0F-44E4-B2C0-CFE249046DC8 Q34464697-891EF271-56DB-4239-830C-A7E789EB60EA Q35487951-DAF0818A-5806-4F5D-BC96-76869C47FAED Q35531454-1D47D5F3-D3D9-439E-9D33-7E603CED4BCC Q35808644-D4C408FE-1147-4AEA-89F2-F8AC6DBBD2F2 Q35973638-EB0AED8F-FC47-4A29-9565-F99BCD384502 Q35998551-FE0C59AD-AAE4-4DE0-9737-D6545FE6EAA1 Q36202621-7D82A983-2F1B-481C-8964-2AC98DE285BC Q36223700-0A220512-A108-4C80-8338-ECB100AEFFAA Q36224671-8B64C526-6D19-4C44-99DF-6BA8DA52477B Q36502511-BE015A88-0E9E-451F-8F88-DBFCED8B7101 Q36911828-96EDB70D-2183-495D-AF61-16416FAE7554 Q37064804-5FD17ABF-0CA2-491D-AB17-7AC16EC763EA Q37064843-93324DC5-CDC9-4CA3-80B1-260367B28BBE Q37143501-D9680A61-6F08-4C40-BA6E-EA59CBE11F18 Q37174550-C49125E7-1F8A-4153-AE16-469AB16EED48 Q37547432-D2AED835-5E36-4F13-AEDD-0B0F51C6605A Q37713866-D4C7B6C9-4792-42D9-958A-7B1E2B19F0CD Q38043556-62916B23-E347-4650-859B-FB7274907710 Q39093234-2F8B2174-A62A-430A-BBCC-1A4B4101EA21 Q39100395-F2283B22-936E-4086-AB58-CA907CE81CC7 Q42272420-2F6573A6-F285-4FE2-89D6-0E8643B3A229 Q47107616-66508015-BBB3-4F27-B8BC-5F2C592C2DF8 Q47253371-CA5D29BF-0E7E-4836-A3AF-6D9FEBB4D1EF Q56781312-F45BEA40-A4BC-4994-A478-BE0BBFE66F3C

P2860

Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease.

http://www.wikidata.org/entity/Q33695621

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Immunization with an attenuate ...... st lethal respiratory disease.

@ast

Immunization with an attenuate ...... st lethal respiratory disease.

@en

type

label

Immunization with an attenuate ...... st lethal respiratory disease.

@ast

Immunization with an attenuate ...... st lethal respiratory disease.

@en

prefLabel

Immunization with an attenuate ...... st lethal respiratory disease.

@ast

Immunization with an attenuate ...... st lethal respiratory disease.

@en

P1433

Q33695621-A498B868-32B4-4458-9649-2BBF6C478715

P1476

Q33695621-90100469-B534-44F6-B1A2-71C97DD77D36

P2093

Q33695621-57572CB6-8529-4FF5-BD4F-3DD80DD090CE

Q33695621-789BFF7D-C005-4C68-8D84-A3926DC8456A

Q33695621-BD73C562-A911-4BD8-86AC-FC49FB042EFD

Q33695621-D3953294-F4C3-4322-97A2-05E609AC77B5

Q33695621-FE98592E-5D96-4A81-AF5D-C18C9E764F1A

P2860

Q33695621-12376905-398D-4B52-9F3E-0B9D65521225

Q33695621-199625D9-5711-436E-AD27-F6D33A7ADB36

Q33695621-1CB4DAA4-E581-4508-8523-7078DCCBE7FF

Q33695621-288E3990-0141-45E0-AF3D-63E45C4AF35B

Q33695621-2B451234-1425-4504-9755-FD9C1DF30848

Q33695621-2B91D656-D81F-41F4-9200-EC2FFD3C81E6

Q33695621-2EF52FC8-F2CE-4F2E-B970-912F2742F9E7

Q33695621-2FBF7BE4-3E2E-4F51-851B-455697124F10

Q33695621-2FDE13E3-D78D-4263-BD55-908E91B0E005

Q33695621-470A66F0-7708-4EA8-98FE-B5DB96DDEC73

P304

Q33695621-2F4E846E-9ED2-4279-945E-7EC941EB383E

P31

Q33695621-351BEAEF-142F-49FC-9A75-69DDA2C49671

P356

Q33695621-3C85BE93-F543-47CE-8AB5-564EDF699527

P407

Q33695621-D5165813-E9EE-40A1-A962-8DB5B5A945BA

P433

Q33695621-82A86086-DE0F-44AE-BE39-8103736AF73B

P478

Q33695621-BDDED460-C369-4B8D-8984-EC047542E2EC

P50

Q33695621-42BCC681-A4DB-4662-BAA1-D28AD1BF1A4C

Q33695621-5B8ACC2C-D814-4E43-A4E7-8B3DFB1FB765

Q33695621-B4BFB75B-6276-49B5-BA18-4C92B93E795F

P577

Q33695621-51F52552-B06E-4280-AA6D-F46D882A279A

P5875

Q33695621-241AC206-72C5-4B58-A24F-7EFB911D0ADC

P698

Q33695621-26C1ABDE-4B8B-46F1-B52D-76F5E654A850

P921

Q33695621-08DD38B3-55D5-493F-9340-64CFF7E8380E

P932

Q33695621-75315005-273F-401E-A4DC-5E764AC48ED3

P356

J.VIROL.2010.01.004

P1433

P1476

Immunization with an attenuate ...... st lethal respiratory disease.

@en

P2093

Enrique Alvarez

http://www.w3.org/2001/XMLSchema#string

Jason Netland

http://www.w3.org/2001/XMLSchema#string

Jincun Zhao

http://www.w3.org/2001/XMLSchema#string

José L Nieto-Torres

http://www.w3.org/2001/XMLSchema#string

Marta L DeDiego

http://www.w3.org/2001/XMLSchema#string

P2860

Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

Bats are natural reservoirs of SARS-like coronaviruses

Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants

Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage

Animal coronavirus vaccines: lessons for SARS.

A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice.

Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines.

Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice.

Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice.

P304

120-128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VIROL.2010.01.004

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

399

http://www.w3.org/2001/XMLSchema#string

P50

Stanley Perlman

P577

2010-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41173415

http://www.w3.org/2001/XMLSchema#string

P698

20110095

http://www.w3.org/2001/XMLSchema#string

P921

P932

2830353

http://www.w3.org/2001/XMLSchema#string